Flinton Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$108K Buy
2,352
+812
+53% +$35.4K ﹤0.01% 758
2019
Q2
$67K Buy
1,540
+560
+57% +$23.6K ﹤0.01% 817
2019
Q1
$43K Buy
+980
New +$49.9K ﹤0.01% 824

Other funds holding SRDX

Flinton Capital Management's SRDX Position: Q3 2019 in Review

Flinton Capital Management increased its Surmodics (SRDX) stake by 53% in Q3 2019, buying an estimated $35.4K and bringing the position to 2,352 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #758.

Flinton Capital Management first reported a position in SRDX in Q1 2019 and has held it in 3 quarters since. 146 funds tracked by Wall St. Rank hold SRDX as of Q3 2019.

  • Flinton Capital Management held 2,352 shares of Surmodics worth $108K as of Q3 2019.
  • Flinton Capital Management bought 812 Surmodics shares in Q3 2019, an estimated $35.4K.
  • Surmodics made up ﹤0.01% of Flinton Capital Management's portfolio in Q3 2019, its #758 holding.
  • Flinton Capital Management first reported a position in Surmodics in Q1 2019 and has held it in 3 quarters since.
  • 146 funds tracked by Wall St. Rank held Surmodics as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.